Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Biomedical Research Support Center, Nagasaki University School of Medicine; Nagasaki, Japan.
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4715-4729. doi: 10.1210/jc.2019-00350.
Regulatory T (Treg) cells and T-helper-17 (Th17) cells may be involved in endometriosis. Information on the pattern of change in the percentages of Treg and Th17 cells in the peripheral blood (PB) and peritoneal fluid (PF) of women with early and advanced endometriosis is unclear.
To investigate the pattern of change in the percentages of Treg and Th17 cells in the PB and PF of women with early and advanced endometriosis.
We recruited 31 women with laparoscopically and histologically confirmed, revised American Society of Reproductive Medicine stage I-II endometriosis, 39 women with stage III-IV endometriosis, and 36 control subjects without visible endometriosis. PB and PF samples were collected and T-cell subpopulations analyzed by flow cytometry using specific monoclonal antibodies recognizing CD4+, CD25+, FOXP3+, and IL-17A+ markers. PF concentrations of TGF-β and IL-17 were measured by ELISA.
The percentages of CD25+FOXP3+ Treg cells within the CD4+ T-cell population were significantly higher in the PF of women with advanced endometriosis than in either early endometriosis or in control subjects (P < 0.05 for both). A persistently lower percentage of CD4+IL-17A+ Th17 cells was found in both PB and PF of women with early and advanced endometriosis. Compared with IL-17 levels, PF levels of TGF-β were significantly higher in women with endometriosis (P = 0.01).
Our findings reconfirmed the current speculation that endometriosis is related to alteration of Treg and Th17 cells in the pelvis causing survival and implantation of ectopic endometrial lesions.
调节性 T(Treg)细胞和辅助性 T 细胞-17(Th17)可能参与子宫内膜异位症的发生。关于早期和晚期子宫内膜异位症患者外周血(PB)和腹腔液(PF)中 Treg 和 Th17 细胞百分比变化模式的信息尚不清楚。
研究早期和晚期子宫内膜异位症患者 PB 和 PF 中 Treg 和 Th17 细胞百分比的变化模式。
我们招募了 31 名经腹腔镜和组织学证实、经美国生殖医学学会修订的 I-II 期子宫内膜异位症患者,39 名 III-IV 期子宫内膜异位症患者和 36 名无可见子宫内膜异位症的对照者。采集 PB 和 PF 样本,使用特异性单克隆抗体识别 CD4+、CD25+、FOXP3+和 IL-17A+标记物,通过流式细胞术分析 T 细胞亚群。通过 ELISA 测量 PF 中 TGF-β 和 IL-17 的浓度。
在晚期子宫内膜异位症患者的 PF 中,CD4+T 细胞群内的 CD25+FOXP3+Treg 细胞百分比明显高于早期子宫内膜异位症患者或对照组(均 P < 0.05)。在早期和晚期子宫内膜异位症患者的 PB 和 PF 中,CD4+IL-17A+Th17 细胞的百分比均持续较低。与 IL-17 水平相比,子宫内膜异位症患者的 PF 中 TGF-β 水平显著升高(P = 0.01)。
我们的研究结果再次证实了目前的推测,即子宫内膜异位症与盆腔中 Treg 和 Th17 细胞的改变有关,导致异位子宫内膜病灶的存活和植入。